Drug intelligence / Profile preview

alpha-ketoanalogues

Development stage
Unknown
Lead developer
Septalyst Lifesciences
Modality
Small Molecules
Administration
Oral
01

Overview

Renolife Forte is a pharmaceutical formulation developed by Septalyst Lifesciences, primarily indicated for the management of chronic kidney disease (CKD). It consists of a combination of alpha-ketoanalogues and essential amino acids. The drug functions as a nitrogen scavenger; when ingested, the ketoanalogues undergo transamination by taking up nitrogen from non-essential amino acids (such as urea precursors) to form their corresponding essential amino acids. This process effectively reduces the production of urea and other nitrogenous waste products, thereby lowering the workload on the kidneys and delaying the progression of renal failure. It is typically prescribed in conjunction with a protein-restricted diet to maintain nutritional status while minimizing uremic symptoms.

Brand names
Renolife ForteRenolife
Other names
Alpha-Keto Analogues of Essential Amino AcidsKetoanalogues

Beyond the preview

Go deeper on alpha-ketoanalogues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-ketoanalogues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call